'What's wrong with having lots of patents?' Federal appeals judge sides with AbbVie in Humira case – Endpoints News
Business News
- ‘What’s wrong with having lots of patents?’ Federal appeals judge sides with AbbVie in Humira case Endpoints News
- AbbVie scores another win in lucrative Humira defense. FiercePharma
- Analysis | This Arthritis Drug Deserves Its Aggressive Patent Protection The Washington Post
- Pharmalittle: AbbVie wins court opinion on Humira patent thickets; Alnylam heart disease drug succeeds in closely watched trial STAT
- Seventh Circuit Throws Out Antitrust Suit Against AbbVie in Welcome Victory for Patent Rights IPWatchdog.com
Source: Business News